LT Pharma
ActiveSummary
The computed 12-month bankruptcy probability of LT Pharma is 3.4% (moderate). For LT Pharma, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €1.1m and a net result of €122,899. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 84% of 6,533 sector peers (NACE 47, financial year 2023). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
2024
31-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 31 days late
28-02
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointmentsCapital conversion · Legal-form conversion · Kind of shares9 facts ▸
Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointments
Capital conversion · Legal-form conversion · Kind of shares9 facts ▸
- General meeting, 29-12-2023
- Other provision, 08-09-2016
- Other provision, “statuts non modifiés depuis constitution” (deed in French)
- Capital conversion, “capital ancien et réserve légale ancienne disponibles pour distribution, article 39,§2,alinéa 3 loi 23-03-2019 introduisant Code des sociétés et des associati…” (deed in French)
- Amendment of the articles
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Kind of shares, “nominative”, 186 (deed in French)
- Director in office, LEDOUX Mathieu (director)
- Power of attorney
2023
31-12
Financial
Equity above €1mequity €1.1m ▲12.4%
A profit in every financial year since 2018 builds equity to €1.1m.
01-09
NBB filing
Annual accounts filed
financial year 2022 · full format · 32 days late
2022
31-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 31 days late
2021
31-12
Financial
Weakest financial yearnet €74,926 ▼57.4%
Net result drops to €74,926, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 30 days late
2020
31-12
NBB filing
Annual accounts filed
financial year 2019 · micro format · 153 days late
31-12
NBB filing
Annual accounts filed
financial year 2018 · micro format · 519 days late
2019
31-12
Financial
Highest result from 2018 to 2023net €405,259 ▲110%
Net result €405,259, the highest in the series.
31-12
Financial
Equity above €500,000equity €616,503 ▲192%
A profit in every financial year since 2018 builds equity to €616,503.
2018
31-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.